>
Switch to:

Biomarin Pharmaceutical Total Inventories

: $749 Mil (As of Sep. 2021)
View and export this data going back to 1999. Start your Free Trial

Biomarin Pharmaceutical's total inventories for the quarter that ended in Sep. 2021 was $749 Mil. Biomarin Pharmaceutical's average total inventories from the quarter that ended in Jun. 2021 to the quarter that ended in Sep. 2021 was $730 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Biomarin Pharmaceutical's Net-Net Working Capital per share for the quarter that ended in Sep. 2021 was $0.13.

Inventory can be measured by days sales of inventory (DSI). Biomarin Pharmaceutical's days sales of inventory (DSI) for the three months ended in Sep. 2021 was 163.01.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Biomarin Pharmaceutical's Days Inventory for the three months ended in Sep. 2021 was 643.54.

Inventory Turnover measures how fast the company turns over its inventory within a year. Biomarin Pharmaceutical's Inventory Turnover for the quarter that ended in Sep. 2021 was 0.14.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biomarin Pharmaceutical's Inventory-to-Revenue for the quarter that ended in Sep. 2021 was 1.79.


Biomarin Pharmaceutical Total Inventories Historical Data

The historical data trend for Biomarin Pharmaceutical's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Total Inventories
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 355.13 475.78 530.87 680.28 698.55

Biomarin Pharmaceutical Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Total Inventories Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 700.85 698.55 713.93 710.98 749.41

Biomarin Pharmaceutical Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Biomarin Pharmaceutical  (NAS:BMRN) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Biomarin Pharmaceutical's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2021 is

Net-Net Working Capital Per Share (Q: Sep. 2021 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1079.476+0.75 * 374.937+0.5 * 749.406-1711.326
-0-0)/183.567
=0.13

2. Inventory can be measured by Days Sales of Inventory (DSI).

Biomarin Pharmaceutical's Days Sales of Inventory for the three months ended in Sep. 2021 is

Days Sales of Inventory (DSI)
=Total Inventories (Q: Sep. 2021 )/Revenue (Q: Sep. 2021 )*Days in Period
=730.1905/408.742*365 / 4
=163.01

3. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biomarin Pharmaceutical's Days Inventory for the three months ended in Sep. 2021 is calculated as:

Days Inventory=Total Inventories (Q: Sep. 2021 )/Cost of Goods Sold (Q: Sep. 2021 )*Days in Period
=730.1905/103.537*365 / 4
=643.54

4. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biomarin Pharmaceutical's Inventory Turnover for the quarter that ended in Sep. 2021 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2021 ) / Total Inventories (Q: Sep. 2021 )
=103.537 / 730.1905
=0.14

5. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biomarin Pharmaceutical's Inventory to Revenue for the quarter that ended in Sep. 2021 is calculated as

Inventory-to-Revenue=Total Inventories (Q: Sep. 2021 ) / Revenue (Q: Sep. 2021 )
=730.1905 / 408.742
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Biomarin Pharmaceutical Total Inventories Related Terms

Thank you for viewing the detailed overview of Biomarin Pharmaceutical's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomarin Pharmaceutical Business Description

Biomarin Pharmaceutical logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Address
770 Lindaro Street, San Rafael, CA, USA, 94901
BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin's Roctavian (hemophilia A gene therapy) and vosoritide (treatment for achondroplasia) are poised to potentially launch in the 2021-22 timeframe.
Executives
Ajer Jeffrey Robert officer: EVP, Chief Commercial Officer C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Heron Elaine J director 6 STONEGATE RD PONTOLA VALLEY CA 94028
Pyott David E I director C/O ALLERGAN 2525 DUPONT DRIVE IRVINE CA 92612
Grey Michael G director C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Fuchs Henry J officer: President, Worldwide R&D C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Acosta Andrea officer: GVP, Chief Accouning Officer C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST SAN RAFAEL CA 94901
Dere Willard H director ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Lawlis V Bryan director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: LAWLIS V BRYAN a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Anderson Elizabeth M director 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Hombach Robert J. director C/O BAXALTA INCORPORATED 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Slamon Dennis director 770 LINDARO STREET SAN RAFAEL CA 94901
Meier Richard A director 1700 E ST ANDREW PLACE SANTA ANA CA 92705
Bienaime Jean Jacques director, officer: Chief Executive Officer 925 PAGE MILL ROAD PALO ALTO CA 94304
Guyer Charles Greg officer: EVP, Chief Technical Officer C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901
Mueller Brian officer: EVP, Chief Financial Officer C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949

Biomarin Pharmaceutical Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)